...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Make your best BET: The emerging role of BET inhibitor treatment in malignant tumors

I am of the opinion that ZEN  will be delivering some good news mainly based on the Newsoara milestone payment. The Chinese do not BET on a pig in a poke, they likely tapped in (Thanks Huawei) or bought information on current trials which caused them to move ahead. The results are rumored to be good and trials with good results do not end abruptly beause the happy patients get unhappy and vocal. Should the prostrate trial be extended, that will be confirmation of good results and the wisdom of Newsoara's milestone payment. 

I am also mindful of the TNBC trial with Pfizer. There are now 11 sites recruiting, 6 in the USA. i suspect that they are close to closing that recruitment of 50? sick bodies. It has been 8 months since they started dosing the first patients and that will give them an idea of the safety profile and probably some response results for those early subjects. The trial is ongoing so they do not have morgues full of test participants. One wonders if any of those patients in the study have expired, terminated or ceased to be. I suspect not as a death would likely have elicited some negative public comment .. "those bastards killed Kimmy"!! Similarly, it has not been shut down for efficacy, probably because they have not dosed and assessed enough patients.

In the absence of bad news, can i assume good news! The ladies are all still walking around with their girls feeling much better, thank you very much?

Despite the $5 MM milestone payment, ZEN, like all Junior biotechs, wil be interested in adding to their cash reserves to cover expenses because science is expensive. I would not be surprised to see another financing not too far down the road. Will they wait for some good news to boost the offering price above the last US$2 sale or will they do the sale pre news to give more US$2 shares to "hint hint nudge nudge wink wink" family, friends, partners and past big investors?

I think i will contact them and ask to be put on their investor list for the next financing --- just in case. "Say no more, say no more!"

Share
New Message
Please login to post a reply